Literature DB >> 8704102

Therapeutic plasma exchange in renal diseases.

F Madore, J M Lazarus, H R Brady.   

Abstract

Plasma exchange has been used extensively for over 2 1/2 decades to treat a variety of renal diseases. In this article, the scientific rationale for therapeutic plasma exchange in primary and secondary glomerulonephritis, thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, myeloma cast nephropathy, and allograft rejection are reviewed. The clinical studies that evaluate its efficacy are summarized, with special emphasis on the results of randomized controlled trials, when available. Consensus plasma exchange regimens are presented for diseases in which there is evidence to support its use.

Entities:  

Mesh：

Year:  1996        PMID： 8704102     DOI： 10.1681/ASN.V73367

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


  17 in total

Review 1.  The complexity of an overlap type resistant cryoglobulinemia: a case report and review of the literature.

Authors:  Milena Tocut; Ziv Rozman; Alexander Biro; Asher Winder; Amir Tanay; Gisele Zandman-Goddard
Journal:  Clin Rheumatol       Date:  2019-01-10       Impact factor: 2.980

2.  Resolution of neurological deficits secondary to spontaneous intracranial haemorrhage and posterior reversible encephalopathy syndrome (PRES) in a patient with hepatitis C-associated cryoglobulinaemia: a role for plasmapheresis.

Authors:  Delshad Ahmad; Haseeb Ilias Basha; Basim Towfiq; Ghassan Bachuwa
Journal:  BMJ Case Rep       Date:  2014-01-20

Review 3.  Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.

Authors:  Sanjeev Baweja; Kate Wiggins; Darren Lee; Susan Blair; Margaret Fraenkel; Lawrence P McMahon
Journal:  J Artif Organs       Date:  2010-12-10       Impact factor: 1.731

4.  [Renal emergencies in cases of collagenosis and vasculitis].

Authors:  M Janneck; C Iking-Konert
Journal:  Z Rheumatol       Date:  2012-06       Impact factor: 1.372

Review 5.  [Pulmonary renal syndrome].

Authors:  K De Groot; W L Gross; A Schnabel
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

6.  Plasma exchange combined with immunosuppressive treatment in a child with rapidly progressive IgA nephropathy.

Authors:  Shuichiro Fujinaga; Yoshiyuki Ohtomo; Daisuke Umino; Hiroshi Mochizuki; Hitohiko Murakami; Toshiaki Shimizu; Yuichiro Yamashiro; Kazunari Kaneko
Journal:  Pediatr Nephrol       Date:  2007-02-07       Impact factor: 3.714

Review 7.  Advances in apheresis therapy for glomerular diseases.

Authors:  Hitoshi Yokoyama; Takashi Wada; Wei Zhang; Hideki Yamaya; Mitsuhiro Asaka
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

8.  Successful steroid treatment in a patient with membranoproliferative glomerulonephritis associated with hepatitis C virus.

Authors:  Toru Sanai; Izumi Watanabe; Tadashi Hirano; Masaru Nakayama; Hironori Sakai; Noriko Uesugi; Kohsuke Masutani; Ritsuko Katafuchi; Hideki Hirakata; Mitsuo Iida
Journal:  Int Urol Nephrol       Date:  2008-02-12       Impact factor: 2.370

Review 9.  Infection and glomerulonephritis.

Authors:  Saraladevi Naicker; June Fabian; Sagren Naidoo; Shoyab Wadee; Graham Paget; Stewart Goetsch
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

10.  Successful treatment of DEAP-HUS with eculizumab.

Authors:  Damien Noone; Aoife Waters; Fred G Pluthero; Denis F Geary; Michael Kirschfink; Peter F Zipfel; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2013-11-20       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.